Form D Explorer

Inspect source fieldsReport a record issue

Form D — Abingworth Clinical Co-Development Fund 3 LP

0002049495-25-000001 · filed Jun 25, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Pooled Investment Fund filings

Offering

Industry
Pooled Investment Fund
Reported offering amount
—
Reported amount sold
$0
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Abingworth Clinical Co-Development Fund 3 LP
CIK
2049495
Entity
Limited Partnership
Jurisdiction
DELAWARE
Year incorporated
2025
Address
1001 PENNSYLVANIA AVENUE, NW
WASHINGTON, District of Columbia 20004
Phone
202-729-5626

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗